These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16208649)

  • 1. Is the outcome of rheumatoid arthritis changed with the use of new disease-modifying antirheumatic drugs?
    Kremer J
    Arthritis Rheum; 2005 Oct; 53(5):636-8. PubMed ID: 16208649
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Bruce IN; Silman AJ; Symmons DP
    J Rheumatol; 2005 Jan; 32(1):6-10. PubMed ID: 15630715
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome issues for rheumatoid arthritis: what do we have and what do we want?
    Albert DA
    J Rheumatol; 2006 Mar; 33(3):441-2. PubMed ID: 16511910
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of deformities (disability) in rheumatoid arthritis].
    Kriegbaum PE
    Ugeskr Laeger; 2000 May; 162(21):3061. PubMed ID: 10850202
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Buckley C; Silman AJ; Symmons DP; Bruce IN
    J Rheumatol; 2005 Jan; 32(1):11-16. PubMed ID: 15700388
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic strategies for rheumatoid arthritis.
    Smolen JS; Steiner G
    Nat Rev Drug Discov; 2003 Jun; 2(6):473-88. PubMed ID: 12776222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutics in rheumatoid arthritis.
    Savage C; St Clair EW
    Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
    van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Ewals JA; Han KH; Hazes JM; Kerstens PJ; Peeters AJ; van Zeben D; Breedveld FC; Huizinga TW; Dijkmans BA; Allaart CF
    Arthritis Rheum; 2009 Jan; 61(1):4-12. PubMed ID: 19116965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Just released from the ASAS factory! First steps towards a disease activity score for ankylosing spondylitis.
    Boers M
    Ann Rheum Dis; 2009 Jan; 68(1):1-2. PubMed ID: 19088258
    [No Abstract]   [Full Text] [Related]  

  • 14. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT; Dijkmans BA
    Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease activity monitoring in rheumatoid arthritis in daily practice: experiences with METEOR, a free online tool.
    Koevoets R; Allaart CF; van der Heijde DM; Huizinga TW
    J Rheumatol; 2010 Dec; 37(12):2632-3. PubMed ID: 21123337
    [No Abstract]   [Full Text] [Related]  

  • 16. Another DMARD option in rheumatoid arthritis?
    Capell HA; Madhok R
    J Rheumatol; 2003 Oct; 30(10):2085-7. PubMed ID: 14528497
    [No Abstract]   [Full Text] [Related]  

  • 17. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    Agarwal S; Zaman T; Handa R
    Singapore Med J; 2009 Jul; 50(7):686-92. PubMed ID: 19644623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of early rheumatoid arthritis.
    Suresh E
    J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are glucocorticoids DMARDs?
    Bijlsma JW; Hoes JN; Van Everdingen AA; Verstappen SM; Jacobs JW
    Ann N Y Acad Sci; 2006 Jun; 1069():268-74. PubMed ID: 16855154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levamisole used in rheumatoid arthritis].
    Veys EM; Mielants H
    Acta Rhumatol; 1979; 3(3):219-30. PubMed ID: 11496645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.